Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  fluoxymesterone
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 36 for your search:
Start Over
Phase II/III Chemotherapy and Hormone Therapy with ADR/VCR/DBD/PRED Followed by TMX/FXM/BLEO/HMM/MTX-CF for Metastatic Stage III/IV or Recurrent Breast Carcinoma
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: under 65
Sponsor:
Protocol IDs: WCCC-CO-7711R, NCI-D80-048-183
Phase II/III Randomized Study of TMX/FXM vs TMX/Danazol for Metastatic Breast Cancer
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: NCI-81-C-72, NCI-MB-153, NCI-T83-1460N, T83-1460
Phase II/III Therapy with TMX vs TMX/FXM for Locally Inoperable, Recurrent, or Metastatic Carcinoma of the Breast
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: NCCTG-813251, MAYO-813251, NCCTG-81-32-51
Phase II/III Multimodality Therapy with Surgery, CTX/ADR/5-FU/TMX/FLU, plus Radiotherapy for Stage III Breast Carcinoma
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 to 69
Sponsor:
Protocol IDs: WCCC-CO-8111, NCI-D81-048-515
Phase III Chemohormonal Therapy with ADR/CCNU/VCR/FXM vs CTX/MPA plus Immunotherapy with C. parvum for Metastatic Renal Carcinoma
Phase: Phase III
Type: Treatment
Status: Closed
Age: 20 to 70
Sponsor:
Protocol IDs: MSHMC-REN-2
Phase III Chemotherapy with Fluoxymesterone, Oxymetholone, Testosterone and Splenectomy for Myeloproliferative Disorders and Refractory Anemia
Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: no age specified
Sponsor:
Protocol IDs: PVSG-2
Phase III Hormonal Therapy with Calusterone vs Fluoxymesterone for Progressive Breast Cancer
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: CBCG-4280, UICC-72059
Phase III Hormone Therapy with FXM Plus Calcium Carbonate/Vitamin D and Calcitonin for Recurrent Breast Carcinoma with Osseous Metastases
Phase: Phase III
Type: Treatment
Status: Closed
Age: postmenopausal
Sponsor:
Protocol IDs: CBCG-4400
Phase III Study of Two CMFVP (CTX/MTX/5-FU/VCR/PRED) Regimens with or without VATH (VBL/ADR/Thiotepa/FXM) as Adjuvant Chemotherapy for Breast Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: 75 and under
Sponsor: NCI
Protocol IDs: CLB-8082, CALGB-8082
Phase III Induction with DAVTH (DBD/ADR/VCR/TMX/HAL) plus Randomized Maintenance for Metastatic or Recurrent Breast Cancer in Men and Women
Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-2181
Phase III CAFTH (CTX/ADR/5-FU/TMX/HAL) Alone or Followed by Radiotherapy for Resected, Locally Advanced Male and Female Breast Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-3181
Phase III Adjuvant Therapy with CMFPT vs CMF(P)TH and TsAVbTH, Followed by TMX vs Observation for Resected Premenopausal Breast Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: premenopausal
Sponsor: NCI
Protocol IDs: EST-5181
Phase III Chemotherapy with DAVcH (DBD/ADR/VCR/HAL) vs TsAVbH (Thiotepa/ADR/VBL/HAL) for Disseminated or Recurrent Breast Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-6181
Phase III Induction with DAVTH (DBD/ADR/VCR/TMX/FXM) Followed by Cyclic Therapy with DAVTH and CMFP (CTX/5-FU/MTX/PRED) for Recurrent Breast Cancer
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NCI-D79-048-184, WCCC-CO-7814
Phase III Chemotherapy with ADR/DBD/TMX vs MITO/TMX vs MITO/TMX/FXM after Prior Systemic Therapy for Metastatic Breast Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-1179, NCI-D79-048-089
Phase III Chemotherapy with ADR/VCR, CTX/5-FU/MTX and PRED for Metastatic Breast Carcinoma with FXM Added for Maintenance
Phase: Phase III
Type: Treatment
Status: Completed
Age: under 65
Sponsor: NCI
Protocol IDs: EST-2173, UICC-73088
Phase III Randomized Comparison of Postoperative Adjuvant Hormonal Therapy with Tamoxifen vs Tamoxifen/Fluoxymesterone in Postmenopausal Women with ER-Positive Breast Cancer
Phase: Phase III
Type: Treatment
Status: Closed
Age: postmenopausal
Sponsor: NCI
Protocol IDs: NCCTG-893052, MAYO-893052, NCCTG-89-30-52
Phase III Randomized Study of Megestrol Acetate vs Fluoxymesterone vs Dexamethasone for the Treatment of Cancer-Related and Cancer Treatment-Related Anorexia and Cachexia
Phase: Phase III
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCCTG-919252, MAYO-919252, NCI-P92-0004
Phase I/II Adjuvant Therapy with CAFTH (CTX/ADR/5-FU/TMX/FXM) with Radiotherapy for Resected Stage I/II Breast Cancer
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: WCCC-CO-8213, NCI-D83-048-628
Start Over